Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

Discrete adipose-derived stem cell subpopulations may display differential functionality after in vitro expansion despite convergence to a common phenotype distribution.

Nielsen FM., Riis SE., Andersen JI., Lesage R., Fink T., Pennisi CP.

Laboratory Study on Chronic Wound, published in Stem Cell Res Ther (2016) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Stem Cell Res Ther (2016)
Country
England
Reported sample size
—
Source database
PubMed
PMID
27906060
PMCID
PMC5134234
DOI
10.1186/s13287-016-0435-8
Citations
25

Abstract (original English)

Background Complex immunophenotypic repertoires defining discrete adipose-derived stem cell (ASC) subpopulations may hold a key toward identifying predictors of clinical utility. To this end, we sorted out of the freshly established ASCs four subpopulations (SPs) according to a specific pattern of co-expression of six surface markers, the CD34, CD73, CD90, CD105, CD146, and CD271, using polychromatic flow cytometry. Method Using flow cytometry-associated cell sorting and analysis, gating parameters were set to select for a CD73 + CD90 + CD105 + phenotype plus one of the four following combinations, CD34 - CD146 - CD271 - (SP1), CD34 - CD146 + CD271 - (SP2), CD34 + CD146 + CD271 - (SP3), and CD34 - CD146 + CD271 + (SP4). The SPs were expanded 700- to 1000-fold, and their surface repertoire, trilineage differentiation, and clonogenic potential, and the capacity to support wound healing were assayed. Results Upon culturing, the co-expression of major epitopes, the CD73, CD90, and CD105 was maintained, while regarding the minor markers, all SPs reverted to resemble the pre-sorted population with CD34 - CD146 - CD271 - and CD34 - CD146 + CD271 - representing the most prevalent combinations, followed by less frequent CD34 + CD146 - CD271 - and CD34 + CD146 + CD271 - variants. There was no difference in the efficiency of adipo-, osteo-, or chondrogenesis by cytochemistry and real-time

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdultAntigens, CDBiological AssayCell DifferentiationCell LineageChondrocytesFlow CytometryGene ExpressionHumans

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research